Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$1,503 Mln
P/E Ratio
11.43
P/B Ratio
1.56
Industry P/E
--
Debt to Equity
0.94
ROE
0.15 %
ROCE
7.17 %
Div. Yield
1.65 %
Book Value
30.94
EPS
4.26
CFO
$721.88 Mln
EBITDA
$890.61 Mln
Net Profit
$258.25 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
CONMED (CNMD)
| -30.36 | -19.17 | -29.59 | -34.39 | -32.39 | -6.86 | -0.22 |
|
BSE Sensex*
| 1.93 | 3.71 | 5.17 | 9.13 | 11.26 | 21.09 | 11.16 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
CONMED (CNMD)
| -37.26 | 23.54 | -37.47 | 27.35 | 1.16 | 75.71 | 27.23 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 14.96 | 10,289.47 | 14.52 | 12.69 | |
| 69.39 | 9,766.86 | 94.68 | 2.52 | |
| 149.24 | 8,221.46 | -- | -25.23 | |
| 270.64 | 10,728.92 | 770.42 | 1.2 |
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot... with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida. Address: 11311 Concept Boulevard, Largo, FL, United States, 33773-4908 Read more
Chairman of the Board, CEO & President
Mr. Curt R. Hartman
Executive VP, CFO & Principal Accounting Officer
Mr. Todd W. Garner CPA
Headquarters
Largo, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of CONMED Corporation (CNMD) stood at $ 2,306 Mln as on 31-Dec-24
The share price of CONMED Corporation (CNMD) is $47.66 (NYSE) as of 21-Apr-2025 16:10 EDT. CONMED Corporation (CNMD) has given a return of -32.39% in the last 3 years.
CONMED Corporation (CNMD) has a market capitalisation of $ 1,503 Mln as on 21-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of CONMED Corporation (CNMD) is 11.43 times as on 21-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the CONMED Corporation (CNMD) and enter the required number of quantities and click on buy to purchase the shares of CONMED Corporation (CNMD).
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida. Address: 11311 Concept Boulevard, Largo, FL, United States, 33773-4908
The CEO & director of Mr. Curt R. Hartman. is CONMED Corporation (CNMD), and CFO & Sr. VP is Mr. Todd W. Garner CPA.
There is no promoter pledging in CONMED Corporation (CNMD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| CONMED Corporation (CNMD) | Ratios |
|---|---|
|
Return on equity(%)
|
14.74
|
|
Operating margin(%)
|
15.33
|
|
Net Margin(%)
|
10.13
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of CONMED Corporation (CNMD) was $0 Mln.
$-0.93
(
